Exec VP, CFO Wolk Joseph J sale 16,820 shares of Johnson & Johnson [JNJ]

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Johnson & Johnson shares valued at $2,975,571 were sold by Wolk Joseph J on Aug 15 ’25. At $176.91 per share, Wolk Joseph J sold 16,820 shares. The insider’s holdings dropped to 14,000 shares worth approximately $2.51 million following the completion of this transaction.

Also, Wolk Joseph J purchased 16,820 shares, netting a total of over 2,975,571 in proceeds.

Before that, REED JOHN C had sold 19,137 shares from its account. In a trade valued at $3,129,830, the EVP, Innovative Medicine, R&D traded Johnson & Johnson shares for $163.55 each. Upon closing the transaction, the insider’s holdings decreased to 19,137 shares, worth approximately $1.91 million.

As published in a research note from Erste Group on July 23, 2025, Johnson & Johnson [JNJ] has been rated up from a Hold to a Buy. Analysts at Leerink Partners downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in mid May. Earlier on November 15, 2024, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for JNJ stock.

Analyzing JNJ Stock Performance

On last trading session, Johnson & Johnson [NYSE: JNJ] rose 0.05% to $178.93. The stock’s lowest price that day was $178.16, but it reached a high of $180.079 in the same session. During the last five days, there has been a surge of approximately 2.41%. Over the course of the year, Johnson & Johnson shares have jumped approximately 12.09%. Shares of the company reached a 52-week high of $180.61 on 08/20/25 and a 52-week low of $140.68 on 01/10/25.

Support And Resistance Levels for Johnson & Johnson (JNJ)

According to the 24-hour chart, there is a support level at 178.03, which, if violated, would cause prices to drop to 177.14. In the upper region, resistance lies at 179.95. The next price resistance is at 180.98. RSI (Relative Strength Index) is 75.71 on the 14-day chart, showing overbought technical sentiment.

Is Johnson & Johnson subject to short interest?

Stocks of Johnson & Johnson saw a sharp rise in short interest on 2025-07-31 jumping by 1.32 million shares to 17.14 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 15.82 million shares. A jump of 7.69% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.0 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.0.

Which companies own the most shares of Johnson & Johnson (JNJ)?

In terms of Johnson & Johnson share price expectations, FactSet research, analysts set an average price target of 162 in the next 12 months, down nearly -9.42% from the previous closing price of $178.84. Analysts anticipate Johnson & Johnson stock to reach 162 by 2025, with the lowest price target being 162. In spite of this, 19 analysts ranked Johnson & Johnson stock as Buy at the end of 2025. On July 23, 2024, Daiwa Securities assigned a price target of “a Neutral” to the stock and downgraded coverage with a $150.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.